Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/14/2026 | $28.00 | Sector Outperform | Scotiabank |
| 4/14/2026 | $28.00 | Overweight | KeyBanc Capital Markets |
| 4/14/2026 | $26.00 | Overweight | Barclays |
| 4/14/2026 | $28.00 | Overweight | Morgan Stanley |
| 4/14/2026 | $27.00 | Outperform | RBC Capital Mkts |
| 4/14/2026 | $26.00 | Overweight | Analyst |
| 4/14/2026 | $27.00 | Overweight | Wells Fargo |
| 4/14/2026 | $29.00 | Buy | BofA Securities |
Janus Living, Inc. (NYSE:JAN) ("Janus Living"), a pure-play senior housing real estate investment trust (REIT), announced today the pricing of its public offering of 25,000,000 shares of its Class A-1 common stock at a price to the public of $25.00 per share. In addition, Janus Living has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class A-1 common stock at the public offering price, less the underwriting discount. The offering is expected to close on June 4, 2026, subject to customary closing conditions. Janus Living expects to use the net proceeds received from the offering to pursue acquisition and investment opportunities that meet
Janus Living, Inc. (NYSE:JAN) ("Janus Living"), a pure-play senior housing real estate investment trust (REIT), announced today the launch of its public offering of 25,000,000 shares of its Class A-1 common stock pursuant to a registration statement on Form S-11 filed with the Securities and Exchange Commission (the "SEC"). Janus Living expects to grant the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class A-1 common stock. Janus Living expects to use the net proceeds received from the proposed offering to pursue acquisition and investment opportunities that meet its investment criteria and for general corporate purposes. BofA Securities, J.P. Mo
Janus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), announced its Board of Directors today declared a pro rata quarterly common stock cash dividend of $0.0174 per share for the first quarter of 2026 and a quarterly common stock cash dividend of $0.1425 per share for the second quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The quarterly dividend reflects an annualized dividend amount of $0.57 per share of common stock. Record Date Payment Date Amount Friday, June 12, 2026 Wednesday, Jun
4 - Janus Living, Inc. (0002100805) (Issuer)
4 - Janus Living, Inc. (0002100805) (Issuer)
4 - Janus Living, Inc. (0002100805) (Issuer)
Scotiabank initiated coverage of Janus Living with a rating of Sector Outperform and set a new price target of $28.00
KeyBanc Capital Markets initiated coverage of Janus Living with a rating of Overweight and set a new price target of $28.00
Barclays initiated coverage of Janus Living with a rating of Overweight and set a new price target of $26.00
424B4 - Janus Living, Inc. (0002100805) (Filer)
EFFECT - Janus Living, Inc. (0002100805) (Filer)
S-11 - Janus Living, Inc. (0002100805) (Filer)
Janus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), announced its Board of Directors today declared a pro rata quarterly common stock cash dividend of $0.0174 per share for the first quarter of 2026 and a quarterly common stock cash dividend of $0.1425 per share for the second quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The quarterly dividend reflects an annualized dividend amount of $0.57 per share of common stock. Record Date Payment Date Amount Friday, June 12, 2026 Wednesday, Jun
Janus Living, Inc. (NYSE:JAN), a pure-play senior housing real estate investment trust (REIT), is scheduled to report first quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, May 5, 2026. Janus Living will host a conference call and webcast on Wednesday, May 6, 2026 at 12:00 p.m. Eastern Time to review its financial performance and operating results. The conference call can be accessed in the following ways: Janus Living's website: https://ir.janusreit.com/events-and-presentations Webcast: https://events.q4inc.com/attendee/263858499. Joining via webcast is recommended for those who will not be asking questions. Telephone: The pa
-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisi
LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors."We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team,"
LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).
LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world's leaders on the role of stress in drug addiction. Tony Isaac, President and Chief Executive Officer of JanOne, commented, "JanOne's mission is to develop non-addictive medications to treat diseases that cause severe pain, thereby m
SC 13G/A - JanOne Inc. (0000862861) (Subject)
SC 13G - JanOne Inc. (0000862861) (Subject)
SC 13G/A - JanOne Inc. (0000862861) (Subject)